Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM (2017) Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 76:2009–2016

Article  PubMed  Google Scholar 

Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C et al (2002) Longterm follow up of childhood lupus nephritis. J Rheumatol 29:2635–2642

PubMed  Google Scholar 

Chan EY, Yap DY, Wong WT, Wong WH, Wong SW, Lin KY, Hui FY, Yee-Ming J, Lam SS, Wong JK, Lai FF, Ho TW, Tong PC, Lai WM, Chan TM, Ma AL (2022) Long-term outcomes of children and adolescents with biopsy-proven childhood-onset lupus nephritis. Kidney Int Rep 8:141–150. https://doi.org/10.1016/j.ekir.2022.10.014

Article  PubMed  PubMed Central  Google Scholar 

Suhlrie A, Hennies I, Gellermann J, Büscher A, Hoyer P, Waldegger S et al (2020) Twelve-month outcome in juvenile proliferative lupus nephritis: results of the German registry study. Pediatr Nephrol 35:1235–1246. https://doi.org/10.1007/s00467-020-04501-x

Article  PubMed  Google Scholar 

Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B et al (2017) European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis 76:1965–1973

Article  CAS  PubMed  Google Scholar 

Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF (2016) Asia-Pacific Lupus Collaboration. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis 75:1615–1621. https://doi.org/10.1136/annrheumdis-2015-207726

Article  CAS  PubMed  Google Scholar 

De Mutiis C, Wenderfer SE, Orjuela A, Bagga A, Basu B, Sar T, Aggarwal A, Jain A, Yap HK, Ito S, Ohnishi A, Iwata N, Kasapcopur O, Laurent A, Mastrangelo A, Ogura M, Shima Y, Rianthavorn P, Silva CA, Trindade V, Dormi A, Tullus K (2022) Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis. Rheumatology (Oxford) 61:2563–2571. https://doi.org/10.1093/rheumatology/keab746

Article  PubMed  Google Scholar 

Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT et al (2018) Revision of the international society of nephrology/renal pathology society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93:789–796

Article  PubMed  Google Scholar 

Marks SD, Pilkington C, Woo P, Dillon MJ (2004) The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology 43:1186–1189

Article  CAS  PubMed  Google Scholar 

Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640

Article  CAS  PubMed  Google Scholar 

Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637. https://doi.org/10.1681/ASN.2008030287

Article  PubMed  PubMed Central  Google Scholar 

Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, Hu Z, Liang Y, Yang Z, Zhong R (2016) Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 26:372–376. https://doi.org/10.3109/14397595.2015.1091136

Article  PubMed  Google Scholar 

Li L, Xia Y, Chen C, Cheng P, Peng C (2015) Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int J Clin Exp Med 8:11026–11031

CAS  PubMed  PubMed Central  Google Scholar 

Soliman WM, Sherif NM, Ghanima IM, El-Badawy MA (2020) Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: relation with disease activity and lupus nephritis. Reumatol Clin (Engl Ed) 16:255–261. https://doi.org/10.1016/j.reuma.2018.07.008

Article  PubMed  Google Scholar 

Wu Y, Chen Y, Yang X, Chen L, Yang Y (2016) Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol 36:94–99. https://doi.org/10.1016/j.intimp.2016.04.006

Article  CAS  PubMed  Google Scholar 

Firooz N, Albert DA, Wallace DJ, Ishimori M, Berel D, Weisman MH (2011) High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 20:588–597. https://doi.org/10.1177/0961203310393378

Article  CAS  PubMed  Google Scholar 

Vilá LM, Alarcón GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2005) LUMINA Study Group. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 32:2150–2155

PubMed  Google Scholar 

Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D’Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D (2018) British society for rheumatology standards, audit and guidelines working group. The British society for rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology (Oxford) 57:e1–e45. https://doi.org/10.1093/rheumatology/kex286

Article  PubMed  Google Scholar 

Abdelrahman N, Beresford MW, Leone V (2019) UK Juvenile-onset Systemic Lupus Erythematosus Study Group. Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients. Lupus 28:667–674. https://doi.org/10.1177/0961203319840699

Article  CAS  PubMed  Google Scholar 

Mirzayan MJ, Schmidt RE, Witte T (2000) Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology (Oxford) 39:1316–1319. https://doi.org/10.1093/rheumatology/39.12.1316

Article  CAS  PubMed  Google Scholar 

Petri M, Singh S, Tesfasyone H, Malik A (2009) Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study. J Rheumatol 36:2476–2480. https://doi.org/10.3899/jrheum.090019

Article  PubMed  Google Scholar 

Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, Li Vecchi M, Messa P, Sinico RA (2009) Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 68:234–237. https://doi.org/10.1136/ard.2008.094508

Article  CAS  PubMed  Google Scholar 

Hajji M, Harzallah A, Kaaroud H, Barbouch S, Hamida FB, Abdallah TB (2017) Factors associated with relapse of lupus nephritis: a single center study of 249 cases. Saudi J Kidney Dis Transpl 28:1349–1355. https://doi.org/10.4103/1319-2442.220863

Article  PubMed  Google Scholar 

Bertsias GK, Salmon JE, Boumpas DT (2010) Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 69:1603–1611. https://doi.org/10.1136/ard.2010.135186

Article  PubMed  Google Scholar 

Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu CY, Hebert LA, Rovin BH (2010) The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 19:1272–1280. https://doi.org/10.1177/0961203310371154

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D’Cruz DP, Isenberg DA, Rahman A (2009) Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther 11:R154. https://doi.org/10.1186/ar2831

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Vollenhoven RF, Bertsias G, Doria A, Isenberg D, Morand E, Petri MA, Pons-Estel BA, Rahman A, Ugarte-Gil MF, Voskuyl A, Arnaud L, Bruce IN, Cervera R, Costedoat-Chalumeau N, Gordon C, Houssiau FA, Mosca M, Schneider M, Ward MM, Alarcon G, Aringer M, Askenase A, Bae SC, Bootsma H, Boumpas DT, Brunner H, Clarke AE, Coney C, Czirják L, Dörner T, Faria R, Fischer R, Fritsch-Stork R, Inanc M, Jacobsen S, Jayne D, Kuhn A, van Leeuw B, Limper M, Mariette X, Navarra S, Nikpour M, Olesinska MH, Pons-Estel G, Romero-Diaz J, Rubio B, Schoenfeld Y, Bonfá E, Smolen J, Teng YKO, Tincani A, Tsang-A-Sjoe M, Vasconcelos C, Voss A, Werth VP, Zakharhova E, Aranow C (2021) 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med 8:e000538. https://doi.org/10.1136/lupus-2021-000538

Article  PubMed  PubMed Central